ALTER: ADJUNCTIVE LINEZOLID FOR THE TREATMENT OF TUBERCULOUS MENINGITIS

ALTER is a randomized interventional trial of the pharmacokinetics and tolerability of adjunctive linezolid in the treatment of patients with tuberculous meningitis from the Masaka Regional Referral Hospital. We are collaborating with Drs. Freddie Kibengo and Fiona Cresswell, along with a stellar team of investigators from the MRC/UVRI site based in Masaka, Uganda. The trial will assess pharmacokinetic, neuropsychological, and functional outcomes, in addition to mortality.

Region: 
East Africa
category research: 
Neuro-Infectious Diseases/Neuro-Immunology
BALANCE Investigators: